التفاصيل البيبلوغرافية
العنوان: |
Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure—A Nested Matched Pair Real-World Study |
المؤلفون: |
Elisabeth Blüthner, Ulrich-Frank Pape, Frank Tacke, Sophie Greif |
المصدر: |
Nutrients; Volume 15; Issue 8; Pages: 1949 |
بيانات النشر: |
Multidisciplinary Digital Publishing Institute |
سنة النشر: |
2023 |
المجموعة: |
MDPI Open Access Publishing |
مصطلحات موضوعية: |
quality of life, SF-36, SBS-QoL TM, teduglutide, glucagon-like peptide-2, parenteral nutrition, stool frequency, sleep disturbances |
جغرافية الموضوع: |
agris |
الوصف: |
Background: Quality of life (QoL) data of chronic intestinal failure (cIF) patients treated with the GLP-2 analogue teduglutide are scarce. This study aims to analyze QoL changes over time in teduglutide-treated patients and compare the results to a matched non-treated cIF control group in a real-world setting. Methods: QoL data (SF-36 and SBS-QoLTM) were obtained from adult cIF patients being treated with teduglutide and compared to previously collected QoL data from a PNLiver trial (DRKS00010993), during which patients had been therapy naive. The dataset was then extended by a pairwise matched control group (non-teduglutide-treated PNLiver trial patients) and follow-up data from this group were collected accordingly. Results: Median teduglutide treatment duration and the follow-up period of controls were both 4.3 years. SBS-QoLTM subscales and the SBS-QoLTM sum score showed significant improvements over time in teduglutide-treated patients, as well as for the SF-36 physical and mental component summary scores (all p < 0.02), while non-treated patients showed no significant changes in any of the mentioned scores. Significant differences of QoL changes between treated and non-treated patients were seen for both SF-36 summary scores (p = 0.031 and 0.012). Conclusions: We herein demonstrate for the first time that QoL significantly improved during teduglutide treatment in SBS-cIF patients in a real-world setting compared to individually matched non-treated SBS-cIF patients, indicating relevant clinical benefits. |
نوع الوثيقة: |
text |
وصف الملف: |
application/pdf |
اللغة: |
English |
Relation: |
Clinical Nutrition; https://dx.doi.org/10.3390/nu15081949 |
DOI: |
10.3390/nu15081949 |
الاتاحة: |
https://doi.org/10.3390/nu15081949 |
Rights: |
https://creativecommons.org/licenses/by/4.0/ |
رقم الانضمام: |
edsbas.EB13EA01 |
قاعدة البيانات: |
BASE |